Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Viganego

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Current Cardiology Reports|April 25, 2016
Arrhythmias and Other Electrophysiology Issues in Cancer Patients Receiving Chemotherapy or RadiationFederico Viganego, Robin Singh, Michael G Fradley
American Heart Journal Plus : Cardiology Research and Practice|July 4, 2025
Changes in health insurance status and mortality in patients with acute heart failureFederico Viganego, Mark K Meiselbach, Michael G Fradley, et al.
Current Treatment Options in Cardiovascular Medicine|March 3, 2016
Anti-VEGF-Induced Hypertension: a Review of Pathophysiology and Treatment OptionsBryan J Brinda, Federico Viganego, Teresa Vo, et al.
International Journal of Cardiology|January 12, 2007
Staphylococcus lugdunensis endocarditis following lower extremity revascularizationFederico Viganego, Talat M Nazir, Ching Y Lee, et al.
Circulation. Cardiovascular Quality and Outcomes|February 24, 2021
Impact of Global Budget Payments on Cardiovascular Care in Maryland: An Interrupted Time Series AnalysisFederico Viganego, Eun K Um, Jasmine Ruffin, et al.
The American Journal of Cardiology|February 24, 2012
Effect of early diagnosis and treatment with percutaneous lead extraction on survival in patients with cardiac device infectionsFederico Viganego, Susan O'Donoghue, Zayd Eldadah, et al.
Autoimmunity|June 25, 2003
Anti-carbonic anhydrase II antibodies in systemic sclerosis: association with lung involvementCristiano Alessandri, Michele Bombardieri, Rossana Scrivo, et al.
Open Heart|January 19, 2018
Rates and risk of arrhythmias in cancer survivors with chemotherapy-induced cardiomyopathy compared with patients with other cardiomyopathiesMichael G Fradley, Federico Viganego, Kevin Kip, et al.
Oncology Reviews|August 8, 2017
Developing a Comprehensive Cardio-Oncology Program at a Cancer Institute: The Moffitt Cancer Center ExperienceMichael G Fradley, Allen C Brown, Bernadette Shields, et al.
Cancer Control : Journal of the Moffitt Cancer Center|June 5, 2020
Electrocardiographic Changes Associated With Ibrutinib ExposureMichael G Fradley, Allan Welter-Frost, Matthew Gliksman, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Cardiology Reports|April 25, 2016
Arrhythmias and Other Electrophysiology Issues in Cancer Patients Receiving Chemotherapy or RadiationFederico Viganego, Robin Singh, Michael G Fradley
American Heart Journal Plus : Cardiology Research and Practice|July 4, 2025
Changes in health insurance status and mortality in patients with acute heart failureFederico Viganego, Mark K Meiselbach, Michael G Fradley, et al.
Current Treatment Options in Cardiovascular Medicine|March 3, 2016
Anti-VEGF-Induced Hypertension: a Review of Pathophysiology and Treatment OptionsBryan J Brinda, Federico Viganego, Teresa Vo, et al.
International Journal of Cardiology|January 12, 2007
Staphylococcus lugdunensis endocarditis following lower extremity revascularizationFederico Viganego, Talat M Nazir, Ching Y Lee, et al.
Circulation. Cardiovascular Quality and Outcomes|February 24, 2021
Impact of Global Budget Payments on Cardiovascular Care in Maryland: An Interrupted Time Series AnalysisFederico Viganego, Eun K Um, Jasmine Ruffin, et al.
The American Journal of Cardiology|February 24, 2012
Effect of early diagnosis and treatment with percutaneous lead extraction on survival in patients with cardiac device infectionsFederico Viganego, Susan O'Donoghue, Zayd Eldadah, et al.
Autoimmunity|June 25, 2003
Anti-carbonic anhydrase II antibodies in systemic sclerosis: association with lung involvementCristiano Alessandri, Michele Bombardieri, Rossana Scrivo, et al.
Open Heart|January 19, 2018
Rates and risk of arrhythmias in cancer survivors with chemotherapy-induced cardiomyopathy compared with patients with other cardiomyopathiesMichael G Fradley, Federico Viganego, Kevin Kip, et al.
Oncology Reviews|August 8, 2017
Developing a Comprehensive Cardio-Oncology Program at a Cancer Institute: The Moffitt Cancer Center ExperienceMichael G Fradley, Allen C Brown, Bernadette Shields, et al.
Cancer Control : Journal of the Moffitt Cancer Center|June 5, 2020
Electrocardiographic Changes Associated With Ibrutinib ExposureMichael G Fradley, Allan Welter-Frost, Matthew Gliksman, et al.
Pageof 2